Maxcyte (MXCT) Other Non-Current Assets (2020 - 2026)
Maxcyte (MXCT) posted quarterly Other Non-Current Assets of $2.6 million for Q1 2026, up 36.37% year-over-year from $1.9 million in Q1 2025, and up 5.63% quarter-over-quarter from $2.5 million in Q4 2025.
Maxcyte (MXCT) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Other Non-Current Assets for 7 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 36.37% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (up 36.37% YoY), while the FY2025 annual figure was $2.5 million, up 61.03% from the prior year.
- Other Non-Current Assets advanced to $2.6 million in Q1 2026 per MXCT's latest filing, from $2.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.8 million in Q2 2025 and bottomed at $295000.0 in Q1 2024.
- Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $1.1 million in 2024.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets slumped 62.15% — and 2025, when it jumped 547.8%.
- Maxcyte's Other Non-Current Assets stood at $809000.0 in 2022, then slumped by 52.04% to $388000.0 in 2023, then surged by 294.85% to $1.5 million in 2024, then surged by 61.03% to $2.5 million in 2025, then climbed by 5.63% to $2.6 million in 2026.
- Business Quant data shows MXCT's Other Non-Current Assets at $2.6 million in Q1 2026, $2.5 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Maxcyte | 146.35 Mn | 146.35 Mn | 5.60 Mn | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Mn |
| Mar 31, 2026 | 2.61 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 640,000.00 |
| Mar 31, 2024 | 295,000.00 |
| Dec 31, 2023 | 388,000.00 |
| Sep 30, 2023 | 619,400.00 |
| Jun 30, 2023 | 597,300.00 |
| Mar 31, 2023 | 399,300.00 |
| Dec 31, 2022 | 809,000.00 |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 920,500.00 |
| Mar 31, 2022 | 1.05 Mn |
| Dec 31, 2021 | 316,700.00 |
| Sep 30, 2021 | 318,100.00 |